Research On Key Audit Items Disclosure Problems And Countermeasures Of Listed Companies In The Pharmaceutical And Biological Industry

In the traditional audit report,the certified public accountants only issue simple and short audit opinions to reflect the audit results,so the users of the audit report have limited information.In 2008,the global financial crisis broke out,which exposed the problem that the traditional audit report could not meet the information needs of investors.In order to solve this problem,the International Auditing and Identification Standards Board(IAASB)issued new audit reporting standards in 2015.China also added a new No.1504 standard in2016,that is,to communicate key audit matters in the audit report.The promulgate of this code is a major improvement in the transparency of audit work,increase the value of audit reports,and bring more useful information to investors.This thesis studies the domestic and foreign literature about key audit matters,the development of audit reporting standards are introduced,this thesis expounds the basic theory of key audit matters,combining with the theory of signal transmission,medical biotechnology company in shenzhen stock exchange from 2017 to 2019 as the research object of audit report,statistics of the whole industry and industry segment disclosure situation of key audit matters,And the reasons for the confirmation of key audit matters and the corresponding procedures are statistically analyzed.It is found that the forms of disclosure of key audit matters in the pharmaceutical and biological industry are gradually standardized,the disclosed audit procedures have certain pertinency,and the disclosure of key audit matters can indeed transfer a certain amount of information.However,there are still some problems in the process of disclosure,such as single reason for confirmation,non-standard expression and widespread templating.On this basis,taking Yan ’an Bikang as an example,this thesis conducts statistical analysis on the key audit matters disclosed in its audit report from 2017 to 2019,and finds that there are problems such as insufficient confirmation,undisclosed important matters and defects in the audit procedures implemented.In order to solve these problems and further improve the information content of audit reports,this thesis puts forward some suggestions and countermeasures,such as unifying the form of expression,disclosing personalized information,perfecting audit procedures,strengthening the supervision of annual reports,and strengthening the education of certified public accountants and information users.The contribution of this thesis is to pharmaceutical biotechnology industry as the research object,combining the theory of signal transmission,and the theory of modern risk-oriented auditing theoretical basis,from the meaning of key audit matters,determine and disclosure requirements on the three dimensions of key audit items,enrich the theory of audit reporting standards research achievements,at the same time for certified public accountants audit work provides a new way of thinking,It has certain practical guiding significance.